Epoetin beta pegol ameliorates flow‐mediated dilation with improving endothelial nitric oxide synthase coupling state in nonobese diabetic rats

BACKGROUND/AIMS: Patients with diabetic nephropathy have a high cardiovascular mortality. Epoetin beta pegol (continuous erythropoietin receptor activator, C.E.R.A.) is a drug for the treatment of renal anemia. In this study, we investigated the effect of C.E.R.A. on vascular endothelial function as...

Descripción completa

Detalles Bibliográficos
Autores principales: Serizawa, Kenichi, Yogo, Kenji, Tashiro, Yoshihito, Kawasaki, Ryohei, Endo, Koichi, Shimonaka, Yasushi, Hirata, Michinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363236/
https://www.ncbi.nlm.nih.gov/pubmed/28054454
http://dx.doi.org/10.1111/1755-5922.12250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363236/
https://www.ncbi.nlm.nih.gov/pubmed/28054454
http://dx.doi.org/10.1111/1755-5922.12250

Ejemplares similares